LANTERN PHARMA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.59 USD | +3.52% |
|
-12.11% | +30.61% |
| 29/05 | Transcript : Lantern Pharma Inc. - Special Call | |
| 24/05 | Lantern Pharma Files $150 Million Mixed Shelf | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 5.81Cr | - | - | - | - | - | |
| 5.69TCr | - | |||||
| 4.03TCr | ||||||
| 3.93TCr | ||||||
| 2.84TCr | ||||||
| 2.64TCr |
- Stock Market
- Equities
- LTRN Stock
- Charts Lantern Pharma Inc.
- Sector Chart
